Dr. Kherani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
525 East 68th Street Mailbox 301
New York Presbyterian- Cornell Weill Medical Center
New York, NY 10021Phone+1 917-892-8495
Education & Training
New York Presbyterian HospitalResidency, Emergency Medicine, 2008 - 2012
Duke University School of MedicineClass of 2008
Certifications & Licensure
NY State Medical License 2010 - 2026
CT State Medical License 2015 - 2018- American Board of Emergency Medicine Emergency Medicine
Publications & Presentations
PubMed
- 71 citationsOvercoming MET-dependent resistance to selective RET inhibition in patients with RET fusion-positive lung cancer by combining selpercatinib with crizotinibEzra Y. Rosen, Melissa Lynne Johnson, Sarah E. Clifford, Romel Somwar, Jennifer Kherani
Clinical Cancer Research. 2021-01-01 - 8 citationsEmergency Radiology "Boot Camp": Educating Emergency Medicine Residents Using E-learning Radiology Modules.Shlomo Minkowitz, Kristen T. Leeman, Ashley E. Giambrone, Jennifer F Kherani, Lily M. Belfi
AEM Education and Training. 2017-01-01 - 25 citationsCommon endothelial progenitor cell assays identify discrete endothelial progenitor cell populationsThomas J. Povsic, Katherine L. Zavodni, Enrikas Vainorius, Jennifer F. Kherani, Pascal J. Goldschmidt-Clermont
American Heart Journal. 2009-02-01
Authored Content
- Response to RET-Specific Therapy in RET Fusion-Positive Anaplastic Thyroid CarcinomaMay 2020
Press Mentions
Clinical Trial: LOXO-305 Faces off Against FDA-Approved Covalent BTK InhibitorsFebruary 19th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
